News

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and Management-09-07-2016
Volume11
Issue 9

CSafe Acquires Kallibox

Author(s):

Pharmaceutical Technology Editors

CSafe completed the acquisition of Kallibox, a manufacturer of cold-chain packaging solutions.

On August 31, 2016, CSafe announced that it has completed the acquisition of Kalibox, a manufacturer of temperature-controlled packaging including insulated shippers, pallet shippers, and refrigerants. Kallibox currently has two manufacturing locations in France. The acquisition of Kallibox continues CSafe's global expansion plans adding more than 5000 square meters of manufacturing in two European locations to its current six North American locations totaling more than 20,000 square meters. These are CSafe’s first owned facilities in Europe.

Source: CSafe

 

Articles in this issue
Putting Shelf-Life to the Test
Putting Shelf-Life to the Test
The Enzymatic Catalysis Route to Going Green
The Enzymatic Catalysis Route to Going Green
PT0816_Outsourcing_Figure-1-New-1472762784733.jpg
CMOs Step Up to Test New Bioprocessing Technology
SGS Opens New Facility in Wiesbaden, Germany
CSafe Acquires Kallibox
CordenPharma in France Reports Successful FDA Inspection
Automated Infrared Microscope Effectively Analyzes Micro Samples
Copley Scientific Launches Products for Tablet Dissolution Testing
Eppendorf Expands Single-Use Vessel Portfolio
PANalytical launches the Empyrean Nano edition
Fuji Health Changes Name to Fuji Chemical Industries USA, Inc.
Regis Technologies Reports Successful FDA Inspection
Evonik Birmingham Laboratories Receives Renewal of EU GMP Certification
Quality Issues Cited at Frontida BioPharm
Recipharm Expands Lyophilization Capacity in Italy

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content
medicine factory scientist worker work in Laboratory Plants Process. medical doctor working research in pharmaceutical industry. | Image Credit: ©Quality Stock Arts – stock.adobe.com
July 25th 2025

Interfering with Interventions in Aseptic Processing

James Agalloco
Addressing human interventions to reduce their impact on contamination requires addressing broader considerations than limiting operator activities. Equipment, automation, procedural and component changes can be utilized to make the aseptic activities safer. This article offers suggestions for reducing the adverse impact of intervention throughout the aseptic process.
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
June 25th 2024

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.
Oil painting of maze with figure finding way through. Perseverance, problem-solving. Birds fly above labyrinth at sunset. Concept of challenges, resilience, journey, overcoming obstacles in business | Image Credit © Vadym - stock.adobe.com
July 25th 2025

CMC and Analytical Gaps in CRLs: Why They Persist Despite FDA Guidance and How You Can Position Yourself for Success

Christopher Cole
Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and analytical issues despite early regulatory guidance. Review key risk points in analytical and tech transfer to better ensure commercial readiness.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Mercury. Element 80 of the periodic table of chemical elements. | Image Credit: © N. Elkha - stock.adobe.com
July 24th 2025

Opposing Reactions as RFK Jr. Removes Thimerosal from Flu Vaccines

Patrick Lavery
Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999.
Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com
July 23rd 2025

ICH Q12 and Post-Approval Changes–Less than Satisfactory State of Affairs

Siegfried Schmitt
Speedier implementation of the Post-Approval Change Management Protocol is essential for it to have a positive effect on supply security, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.